Search Results - "Geist, Marcus"
-
1
Minor contribution of cytochrome P450 3A activity on fentanyl exposure in palliative care cancer patients
Published in Scientific reports (10-10-2019)“…Transdermal fentanyl is widely used to control pain in cancer patients. The high pharmacokinetic variability of fentanyl is assumed to be due to cytochrome…”
Get full text
Journal Article -
2
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapies
Published in Basic & clinical pharmacology & toxicology (01-08-2019)“…Cytochrome P450 3A (CYP3A) is the most relevant drug‐metabolizing enzyme in human beings involved in the elimination of about 50% of the marketed drugs…”
Get full text
Journal Article -
3
Steady-state pharmacokinetics and metabolism of voriconazole in patients
Published in Journal of antimicrobial chemotherapy (01-11-2013)“…Voriconazole exhibits non-linear pharmacokinetics in adults and is said to be mainly metabolized by CYP2C19 and CYP3A4 to voriconazole-N-oxide. The aim of this…”
Get full text
Journal Article -
4
Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions
Published in Basic & clinical pharmacology & toxicology (01-01-2019)“…Posaconazole prophylaxis is recommended for patients with acute myeloid leukaemia during induction chemotherapy. Although a tablet formulation with better oral…”
Get full text
Journal Article -
5
Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid
Published in Journal of palliative care (01-04-2017)“…Background: Persistent bleeding is a common reason for admitting patients with advanced cancer to a palliative care unit. Several reports show a successful…”
Get full text
Journal Article -
6
In Vivo CYP3A Activity in Palliative Care Patients: Study Protocol for a Single Arm Prospective Trial
Published in Journal of palliative medicine (01-05-2018)“…Drug interactions are a common cause for escalation of debilitating symptoms in palliative care patients. CYP3A is the most relevant CYP enzyme in humans…”
Get more information
Journal Article -
7
-
8
Safety of voriconazole in a patient with CYP2C92/CYP2C92 genotype
Published in Antimicrobial agents and chemotherapy (01-09-2006)Get full text
Journal Article -
9
Stream temperature data collection standards for Alaska: Minimum standards to generate data useful for regional-scale analyses
Published in Journal of hydrology. Regional studies (01-09-2015)“…Statewide interest in thermal patterns and increasing data collection efforts provides Alaska’s scientific and resource management communities an opportunity…”
Get full text
Journal Article -
10
Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3A
Published in Palliative medicine (01-07-2019)“…Background: Cytochrome P450 3A is the most relevant drug-metabolizing enzyme in humans as it is involved in the elimination of 50% of marketed drugs. Nothing…”
Get full text
Journal Article -
11
Treatment-Refractory Pain
Published in Deutsche medizinische Wochenschrift (1946) (01-09-2018)“…Pain therapy concepts should be based on a biopsychosocial model. A prerequisite for adequate pain therapy is the detailed medical history. The questions about…”
Get more information
Journal Article -
12
Bleeding Control in Palliative Care Patients With the Help of Tranexamic Acid
Published in Journal of palliative care (01-04-2017)“…BACKGROUNDPersistent bleeding is a common reason for admitting patients with advanced cancer to a palliative care unit. Several reports show a successful…”
Get full text
Report